163 related articles for article (PubMed ID: 35855033)
1. A retrospective study of 43 cases of fungal malignant external otitis.
Halwani C; Mtibaa L; Hamdi ME; Baccouchi N; Benmhamed R; Jemli B; Akkari K
Pan Afr Med J; 2022; 41():287. PubMed ID: 35855033
[TBL] [Abstract][Full Text] [Related]
2. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.
Kiakojuri K; Mahdavi Omran S; Roodgari S; Taghizadeh Armaki M; Hedayati MT; Shokohi T; Haghani I; Javidnia J; Kermani F; Badali H; Abastabar M
Mycopathologia; 2021 May; 186(2):245-257. PubMed ID: 33718990
[TBL] [Abstract][Full Text] [Related]
3. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
[TBL] [Abstract][Full Text] [Related]
4. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North-Western Iran.
Roohi B; Nemati S; Alipour A; Faeli L; Mayahi S; Haghani I; Shalchizadeh M; Darini A; Al-Hatmi AMS; Abastabar M; Shokohi T
Mycoses; 2023 Feb; 66(2):87-97. PubMed ID: 36134511
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
[TBL] [Abstract][Full Text] [Related]
7. A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus.
Ito Y; Inoue N; Kaneko N; Otsuka M; Yamasaki S; Yoshikawa M
J Infect Chemother; 2023 Aug; 29(8):809-811. PubMed ID: 37094768
[TBL] [Abstract][Full Text] [Related]
8. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
9. Fungal necrotizing external otitis: diagnosis, management and outcomes of 15 cases.
Korbi AE; Houas J; Kolsi N; Bouatay R; Ferjaoui M; Toumi A; Harrathi K; Koubaa J
Pan Afr Med J; 2022; 42():306. PubMed ID: 36425541
[TBL] [Abstract][Full Text] [Related]
10. Otomycosis: Diagnosis and treatment.
Vennewald I; Klemm E
Clin Dermatol; 2010 Mar; 28(2):202-11. PubMed ID: 20347664
[TBL] [Abstract][Full Text] [Related]
11. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
12. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.
Szigeti G; Kocsubé S; Dóczi I; Bereczki L; Vágvölgyi C; Varga J
Mycopathologia; 2012 Aug; 174(2):143-7. PubMed ID: 22359155
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Borghi E; Iatta R; Sciota R; Biassoni C; Cuna T; Montagna MT; Morace G
J Clin Microbiol; 2010 Sep; 48(9):3153-7. PubMed ID: 20631105
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.
Gharaghani M; Halvaeezadeh M; Ali Jalaee G; Taghipour S; Kiasat N; Zarei Mahmoudabadi A
Curr Med Mycol; 2020 Jun; 6(2):18-22. PubMed ID: 33628977
[TBL] [Abstract][Full Text] [Related]
16. [Fungal otitis externa in children: principles of diagnosis and rational therapy].
Kryukov AI; Kunelskaya NL; Kunelskaya VY; Ivoylov AY; Shadrin GB; Machulin AI
Vestn Otorinolaringol; 2020; 85(1):60-63. PubMed ID: 32241991
[TBL] [Abstract][Full Text] [Related]
17. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
18. Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents.
Giacobino J; Montelli AC; Barretti P; Bruder-Nascimento A; Caramori JT; Barbosa L; Bagagli E
Med Mycol; 2016 Oct; 54(7):725-732. PubMed ID: 27143636
[TBL] [Abstract][Full Text] [Related]
19. Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.
Ali K; Hamed MA; Hassan H; Esmail A; Sheneef A
Int Arch Otorhinolaryngol; 2018 Oct; 22(4):400-403. PubMed ID: 30357045
[No Abstract] [Full Text] [Related]
20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
